RUNX3 and neoplasm: In a hepatocellular carcinoma model, GPC3-BBz CAR-T cells with RUNX3 overexpression exhibited better tumor control, with increased CAR-T cell numbers in blood and tumor tissue, along with a higher proportion of Tem cells (18).